Stock listing
DTIL Stock Price, News, Filings & Events — Precision Biosciences, Inc.
Selected listing: DTIL · NASDAQ · USD · US
This page tracks Precision Biosciences, Inc.'s DTIL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DTIL:NASDAQ. DTIL:NASDAQ is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.
- Ticker
- DTIL:NASDAQ
- Asset type
- Stock
- Market cap
- $197.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Precision Biosciences, Inc. DTIL:NASDAQ stock context
This page tracks Precision Biosciences, Inc.'s DTIL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DTIL:NASDAQ. DTIL:NASDAQ is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.
Latest news from Precision Biosciences, Inc.
D2L Inc. Announces Second Quarter 2027 Financial Results
September 9, 2026
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
August 24, 2026
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
July 31, 2026
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
July 27, 2026
Research Precision Biosciences, Inc.
Precision Biosciences, Inc. investor report
Review AI stock analysis and investor report context for DTIL:NASDAQ.
Precision Biosciences, Inc. company profile
View the public company page for Precision Biosciences, Inc. on 6ix.
Precision Biosciences, Inc. news
Read company news and market updates connected to Precision Biosciences, Inc..
Precision Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Precision Biosciences, Inc..
Alternate listings
PBS0:GETTEX
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
A400AS:LSX
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
A400AS:LS
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:SWB
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
DTIL:BOATS
US · USD
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:FWB
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:DUS
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:HAM
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:MUN
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.
PBS0:TRADEGATE
DE · EUR
Alternate listing for Precision Biosciences, Inc.; the primary context on this page is DTIL:NASDAQ.